Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

NCT06649474 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Resectable Pancreatic Adenocarcinoma
Adenocarcinoma
Resectable Esophageal Cancer
Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Oesophagogastric Cancer

Interventions

BIOLOGICAL: assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy

Sponsor

University Hospital, Clermont-Ferrand